ESMO PracticeUpdate Conference Series:
Videos from #ESMO20 on CNS Malignancies
Key Takeaways from ESMO: Enhancing Prognostication for Glioblastoma
Roger Stupp
- What prognostic variables have historically been most important for patients with glioblastoma?
- Do we learn anything about these traditional prognostic bio-markers from the presentations at this conference?
Key Takeaways from ESMO: Managing Brain Metastases
Manmeet Ahluwalia
- Could you outline some of the key research in brain metastases presented at this year's ESMO?
- How was the study designed?
- As a neuro-oncologist, what stood out to you?
- How does this compare to other therapies in the NSCLC brain metastases setting?
- What other studies were particularly important in the context of managing brain metastases from lung cancer?
- What impact did osimertinib have on brain metastases?
- What other drugs showed promise in this setting?
The ESMO PU Conference Series – A collaboration brought to you by Elsevier’s PracticeUpdate and the European Society for Medical Oncology.
